Pharmacists’ prescribing of opioids in Nova Scotia under Health Canada’s Controlled Drugs and Substances Act temporary exemption during the COVID-19 pandemic
Gespeichert in:
Veröffentlicht in: | Canadian pharmacists journal 2024-09, Vol.157 (5), p.240-245 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 245 |
---|---|
container_issue | 5 |
container_start_page | 240 |
container_title | Canadian pharmacists journal |
container_volume | 157 |
creator | Watema-Lord, Ronald Sketris, Ingrid Neville, Heather Asbridge, Mark Sanyal, Chiranjeev |
description | |
doi_str_mv | 10.1177/17151635241267008 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11418243</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_17151635241267008</sage_id><sourcerecordid>3108764965</sourcerecordid><originalsourceid>FETCH-LOGICAL-c349t-88af37ab526634195df9310c0264e65408dc5049895dd00877e4503013cb8fa73</originalsourceid><addsrcrecordid>eNp1ks9u1DAQxiMEoqXwAFyQJS5cUjyxHScnVKVAK1UUqYC4RV7b2XWV2KntVHDjNTjyajwJs9pS_omLPdL8vpn57CmKx0APAaR8DhIE1ExUHKpaUtrcKfahBVZKCh_vYoz5cgvsFQ9SuqSUc06b-8UeaxkIxtv94tvbjYqT0i7l9P3LVzJHm3R0K-fXJAwkzC44k4jz5E24VuRCh-wUWbyxkZxYNeYN6ZRXRqE4kS74HMM4WkOO47JORHlDLpZVysprm8iRziTbaQ5Rxc_EfsIwu-CJWeK2Yd5Y0p1_OD0uoSUzau3k9MPi3qDGZB_d3AfF-1cv33Un5dn569Pu6KzUaCSXTaMGJtVKVHXNOLTCDGiSalrV3NYCfRstKG8bzBh8KiktF5RRYHrVDEqyg-LFru68rCZrtEUrauzn6CYctg_K9X9mvNv063DdA3BoKs6wwrObCjFcLTblfnJJ23FU3oYl9ThOI2ve1gLRp3-hl2GJHv1tKSEAD4oU7CgdQ0rRDrfTAO23G9D_swGoefK7jVvFzy9H4HAHJLW2v9r-v-IPr8G7aw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3105511050</pqid></control><display><type>article</type><title>Pharmacists’ prescribing of opioids in Nova Scotia under Health Canada’s Controlled Drugs and Substances Act temporary exemption during the COVID-19 pandemic</title><source>SAGE Complete A-Z List</source><source>PubMed Central</source><creator>Watema-Lord, Ronald ; Sketris, Ingrid ; Neville, Heather ; Asbridge, Mark ; Sanyal, Chiranjeev</creator><creatorcontrib>Watema-Lord, Ronald ; Sketris, Ingrid ; Neville, Heather ; Asbridge, Mark ; Sanyal, Chiranjeev</creatorcontrib><identifier>ISSN: 1715-1635</identifier><identifier>EISSN: 1913-701X</identifier><identifier>DOI: 10.1177/17151635241267008</identifier><identifier>PMID: 39315349</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Research and Clinical</subject><ispartof>Canadian pharmacists journal, 2024-09, Vol.157 (5), p.240-245</ispartof><rights>The Author(s) 2024</rights><rights>The Author(s) 2024 2024 Canadian Pharmacists Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c349t-88af37ab526634195df9310c0264e65408dc5049895dd00877e4503013cb8fa73</cites><orcidid>0000-0003-3677-8036</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11418243/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11418243/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,21800,27905,27906,43602,43603,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39315349$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Watema-Lord, Ronald</creatorcontrib><creatorcontrib>Sketris, Ingrid</creatorcontrib><creatorcontrib>Neville, Heather</creatorcontrib><creatorcontrib>Asbridge, Mark</creatorcontrib><creatorcontrib>Sanyal, Chiranjeev</creatorcontrib><title>Pharmacists’ prescribing of opioids in Nova Scotia under Health Canada’s Controlled Drugs and Substances Act temporary exemption during the COVID-19 pandemic</title><title>Canadian pharmacists journal</title><addtitle>Can Pharm J (Ott)</addtitle><subject>Research and Clinical</subject><issn>1715-1635</issn><issn>1913-701X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>AFRWT</sourceid><recordid>eNp1ks9u1DAQxiMEoqXwAFyQJS5cUjyxHScnVKVAK1UUqYC4RV7b2XWV2KntVHDjNTjyajwJs9pS_omLPdL8vpn57CmKx0APAaR8DhIE1ExUHKpaUtrcKfahBVZKCh_vYoz5cgvsFQ9SuqSUc06b-8UeaxkIxtv94tvbjYqT0i7l9P3LVzJHm3R0K-fXJAwkzC44k4jz5E24VuRCh-wUWbyxkZxYNeYN6ZRXRqE4kS74HMM4WkOO47JORHlDLpZVysprm8iRziTbaQ5Rxc_EfsIwu-CJWeK2Yd5Y0p1_OD0uoSUzau3k9MPi3qDGZB_d3AfF-1cv33Un5dn569Pu6KzUaCSXTaMGJtVKVHXNOLTCDGiSalrV3NYCfRstKG8bzBh8KiktF5RRYHrVDEqyg-LFru68rCZrtEUrauzn6CYctg_K9X9mvNv063DdA3BoKs6wwrObCjFcLTblfnJJ23FU3oYl9ThOI2ve1gLRp3-hl2GJHv1tKSEAD4oU7CgdQ0rRDrfTAO23G9D_swGoefK7jVvFzy9H4HAHJLW2v9r-v-IPr8G7aw</recordid><startdate>20240901</startdate><enddate>20240901</enddate><creator>Watema-Lord, Ronald</creator><creator>Sketris, Ingrid</creator><creator>Neville, Heather</creator><creator>Asbridge, Mark</creator><creator>Sanyal, Chiranjeev</creator><general>SAGE Publications</general><general>SAGE PUBLICATIONS, INC</general><scope>AFRWT</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3677-8036</orcidid></search><sort><creationdate>20240901</creationdate><title>Pharmacists’ prescribing of opioids in Nova Scotia under Health Canada’s Controlled Drugs and Substances Act temporary exemption during the COVID-19 pandemic</title><author>Watema-Lord, Ronald ; Sketris, Ingrid ; Neville, Heather ; Asbridge, Mark ; Sanyal, Chiranjeev</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c349t-88af37ab526634195df9310c0264e65408dc5049895dd00877e4503013cb8fa73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Research and Clinical</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Watema-Lord, Ronald</creatorcontrib><creatorcontrib>Sketris, Ingrid</creatorcontrib><creatorcontrib>Neville, Heather</creatorcontrib><creatorcontrib>Asbridge, Mark</creatorcontrib><creatorcontrib>Sanyal, Chiranjeev</creatorcontrib><collection>Sage Journals GOLD Open Access 2024</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Canadian pharmacists journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Watema-Lord, Ronald</au><au>Sketris, Ingrid</au><au>Neville, Heather</au><au>Asbridge, Mark</au><au>Sanyal, Chiranjeev</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacists’ prescribing of opioids in Nova Scotia under Health Canada’s Controlled Drugs and Substances Act temporary exemption during the COVID-19 pandemic</atitle><jtitle>Canadian pharmacists journal</jtitle><addtitle>Can Pharm J (Ott)</addtitle><date>2024-09-01</date><risdate>2024</risdate><volume>157</volume><issue>5</issue><spage>240</spage><epage>245</epage><pages>240-245</pages><issn>1715-1635</issn><eissn>1913-701X</eissn><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>39315349</pmid><doi>10.1177/17151635241267008</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-3677-8036</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1715-1635 |
ispartof | Canadian pharmacists journal, 2024-09, Vol.157 (5), p.240-245 |
issn | 1715-1635 1913-701X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11418243 |
source | SAGE Complete A-Z List; PubMed Central |
subjects | Research and Clinical |
title | Pharmacists’ prescribing of opioids in Nova Scotia under Health Canada’s Controlled Drugs and Substances Act temporary exemption during the COVID-19 pandemic |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T12%3A31%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacists%E2%80%99%20prescribing%20of%20opioids%20in%20Nova%20Scotia%20under%20Health%20Canada%E2%80%99s%20Controlled%20Drugs%20and%20Substances%20Act%20temporary%20exemption%20during%20the%20COVID-19%20pandemic&rft.jtitle=Canadian%20pharmacists%20journal&rft.au=Watema-Lord,%20Ronald&rft.date=2024-09-01&rft.volume=157&rft.issue=5&rft.spage=240&rft.epage=245&rft.pages=240-245&rft.issn=1715-1635&rft.eissn=1913-701X&rft_id=info:doi/10.1177/17151635241267008&rft_dat=%3Cproquest_pubme%3E3108764965%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3105511050&rft_id=info:pmid/39315349&rft_sage_id=10.1177_17151635241267008&rfr_iscdi=true |